Drug intelligence / Profile preview

thioctic acid

Development stage
Unknown
Lead developer
Ludwig Maximilian University of Munich
Modality
Small Molecules
Administration
Oral
01

Overview

Thioctic acid, commonly known as alpha-lipoic acid (ALA), is a naturally occurring organosulfur compound that functions as a potent antioxidant and an essential cofactor for mitochondrial multienzyme complexes, such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. It plays a critical role in energy metabolism and the regulation of oxidative stress by scavenging reactive oxygen species and regenerating endogenous antioxidants like glutathione and vitamins C and E. In clinical research, thioctic acid has been extensively studied for its neuroprotective and vasculoprotective properties. Notably, the Phase 3 RETIPON trial, led by Ludwig-Maximilians University of Munich, investigated its potential to prevent the development of diabetic macular edema (DME) in patients with type 2 diabetes and early-stage retinopathy. While widely available as a dietary supplement, it is also approved as a pharmaceutical product in certain regions for the treatment of diabetic polyneuropathy.

Brand names
ThiotexThiotex 600Thiotex600Thiotex-600Thiotex 300Thiotex300Thiotex-300
Other names
1,2-dithiolane-3-valeric acidalpha-lipoic acidALA1,2-dithiolane-3-pentanoic acid6,8-dithiooctanoic acid
02

Targets

OGDH (Dihydrolipoamide S-succinyltransferase)DLD (Dihydrolipoamide dehydrogenase)DBT (Branched-chain alpha-keto acid dehydrogenase E2 component)DLAT (Dihydrolipoamide S-acetyltransferase)

Beyond the preview

Go deeper on thioctic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thioctic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call